David Veitch
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
David Veitch is Chief Executive Officer at Basilea Pharmaceutica AG since 2018, with employment at the firm starting in 2014.
Formerly, Mr. Veitch was President-European Operations at Savient Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, Mr. Veitch was SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2007 to 2011.
Education includes an undergraduate degree from the University of Bristol.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,19 % | 31/12/2025 | 25.660 ( 0,19 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Director Ejecutivo | 19/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.